Aarschot, Belgium – September19, 2024.–Amnovis, a leader in 3D printed titanium implant manufacturing, has reached a significant milestone, delivering over 50,000 titanium implants since 2021 using its groundbreaking, heat treatment-free 3D printing process. This innovative technology is transforming the production of spinal, orthopedic, and cranio-maxillofacial (CMF) implants, allowing customers to benefit from unmatched production speed, cost efficiency, and reduced time to market.
With this game-changing process, Amnovis eliminates the need for heat treatment in titanium 3D printing, which not only simplifies the production workflow but also accelerates time to market for OEMs. Ruben Wauthle, CEO and Co-founder of Amnovis, explained, “We developed and validated a proprietary process for pure titanium that requires no heat treatment. This unique process allows us to deliver faster, more cost-effective solutions for our customers while maintaining the highest quality standards.”
privelop-spine, one of Amnovis’ partners, has reaped the rewards of this process. Henning Kloss, CEO of privelop-spine, shared, “Since partnering with Amnovis, we’ve been impressed by their production quality and specialist expertise. Surgeons consistently praise the detailed resolution, look, and feel of our implant structures, while distributors and users appreciate the reliability and punctual delivery.”
He further added, “Amnovis’ heat treatment-free titanium process has significantly streamlined our production, reducing time and costs. Their production capacity and reliability have made a substantial contribution to our collaboration with large customers, helping us bring products to market faster.”
In addition to its heat treatment-free process, Amnovis offers a full range of traditional titanium 3D printing services, including Ti-6Al-4V grade 23 with classical heat treatments such as HIP (Hot Isostatic Pressing), giving OEMs the flexibility to choose the most suitable manufacturing method for their needs.Amnovis will be showcasing these capabilities at the NASS 39th Annual Meeting in Chicago from September 25-27 at booth 4008.
Looking ahead, Amnovis remains committed to further improving its processes, expanding production capacities, and continuing to provide cost-effective, cutting-edge solutions for spinal, orthopedic, and CMF applications.
ABOUT AMNOVIS
Amnovis is a pioneering company specializing in advanced additive manufacturing solutions for the medical device industry. With a focus on innovation, quality, and efficiency, Amnovis partners with OEMs worldwide to deliver state-of-the-art implants and instruments that meet the highest industry standards. Our FDA Master File further streamlines the regulatory process for our customers, accelerating time to market while maintaining strict compliance.
For more information, visit www.amnovis.com or follow Amnovis onLinkedIn.